Perseris

News

Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia.

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.